“Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis”, EJMED, vol. 5, no. 3, pp. 1–2, May 2023, doi: 10.24018/ejmed.2023.5.3.1697.